CN109627319B - 一种抗her-2的重链抗体及其应用 - Google Patents
一种抗her-2的重链抗体及其应用 Download PDFInfo
- Publication number
- CN109627319B CN109627319B CN201910027926.2A CN201910027926A CN109627319B CN 109627319 B CN109627319 B CN 109627319B CN 201910027926 A CN201910027926 A CN 201910027926A CN 109627319 B CN109627319 B CN 109627319B
- Authority
- CN
- China
- Prior art keywords
- heavy chain
- chain antibody
- seq
- nucleic acid
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027926.2A CN109627319B (zh) | 2019-01-11 | 2019-01-11 | 一种抗her-2的重链抗体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027926.2A CN109627319B (zh) | 2019-01-11 | 2019-01-11 | 一种抗her-2的重链抗体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109627319A CN109627319A (zh) | 2019-04-16 |
CN109627319B true CN109627319B (zh) | 2022-06-21 |
Family
ID=66060678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910027926.2A Active CN109627319B (zh) | 2019-01-11 | 2019-01-11 | 一种抗her-2的重链抗体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109627319B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022127889A1 (zh) * | 2020-12-18 | 2022-06-23 | 江苏先声药业有限公司 | Her2抗体及其应用 |
CN114409787A (zh) * | 2022-02-18 | 2022-04-29 | 南京英瀚斯生物科技有限公司 | 一种针对her3纳米抗体的分离纯化方法 |
CN117362440A (zh) * | 2022-06-30 | 2024-01-09 | 复旦大学 | Her2纳米抗体及偶联物的制备方法和用途 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007094842A2 (en) * | 2005-12-02 | 2007-08-23 | Genentech, Inc. | Binding polypeptides and uses thereof |
CN102321175A (zh) * | 2011-09-21 | 2012-01-18 | 天津胜发生物技术有限公司 | 针对乳腺癌Her2/new的纳米抗体或多肽 |
CN106046152A (zh) * | 2016-07-07 | 2016-10-26 | 南昌大学 | 特异性识别组氨酸标签的纳米抗体 |
CN106117350A (zh) * | 2016-07-07 | 2016-11-16 | 南昌大学 | 一种免疫库来源的结合免疫球蛋白Fc段的纳米抗体 |
CN106866823A (zh) * | 2017-03-08 | 2017-06-20 | 康众(北京)生物科技有限公司 | 一种抗Her2的纳米抗体 |
CN109096401A (zh) * | 2017-06-20 | 2018-12-28 | 苏州纳洛迈生物科技有限公司 | 抗Her2纳米抗体及其编码序列和用途 |
-
2019
- 2019-01-11 CN CN201910027926.2A patent/CN109627319B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007094842A2 (en) * | 2005-12-02 | 2007-08-23 | Genentech, Inc. | Binding polypeptides and uses thereof |
CN102321175A (zh) * | 2011-09-21 | 2012-01-18 | 天津胜发生物技术有限公司 | 针对乳腺癌Her2/new的纳米抗体或多肽 |
CN106046152A (zh) * | 2016-07-07 | 2016-10-26 | 南昌大学 | 特异性识别组氨酸标签的纳米抗体 |
CN106117350A (zh) * | 2016-07-07 | 2016-11-16 | 南昌大学 | 一种免疫库来源的结合免疫球蛋白Fc段的纳米抗体 |
CN106866823A (zh) * | 2017-03-08 | 2017-06-20 | 康众(北京)生物科技有限公司 | 一种抗Her2的纳米抗体 |
CN109096401A (zh) * | 2017-06-20 | 2018-12-28 | 苏州纳洛迈生物科技有限公司 | 抗Her2纳米抗体及其编码序列和用途 |
Non-Patent Citations (1)
Title |
---|
抗人Her2抗原羊驼纳米抗体的筛选与鉴定;王兰东等;《军事医学》;20170331;第41卷(第3期);184-189 * |
Also Published As
Publication number | Publication date |
---|---|
CN109627319A (zh) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109627319B (zh) | 一种抗her-2的重链抗体及其应用 | |
CN109705215B (zh) | 一种具有高特异性识别黄曲霉毒素b1的纳米抗体2018afb-n11及其应用 | |
CN109232739B (zh) | 一种抗cd38纳米抗体、编码基因及应用 | |
CN112111011B (zh) | 一种特异性抗噻虫嗪抗体的可变区序列及其重组全长抗体 | |
CN111825767B (zh) | 一种人表皮生长因子受体2的单域抗体、检测试剂盒及其应用 | |
CN110577594B (zh) | 一种金黄色葡萄球菌肠毒素a纳米抗体a21、应用及试剂盒 | |
CN112010969B (zh) | 一种高亲和力增强绿色荧光蛋白纳米抗体及其编码基因的筛选方法 | |
CN106854244B (zh) | 一种针对her3的纳米抗体及其临床应用 | |
CN105524173B (zh) | 一种针对人源抗体Fc片段的纳米抗体及其应用 | |
CN108530538B (zh) | EpCAM单域抗体E6 | |
CN111471109B (zh) | 一种抗成纤维细胞生长因子受体4单克隆抗体及其制备方法和用途 | |
CN109748966B (zh) | 一种抗His标签的重链抗体及其应用 | |
CN109776681B (zh) | 一种抗免疫球蛋白Fc段的重链抗体及其应用 | |
CN114349861B (zh) | 一种抗pd1纳米抗体及其制备方法和应用 | |
CN106928358B (zh) | 一种CD105纳米抗体Nb168 | |
CN106928355B (zh) | 一种CD105纳米抗体Nb184 | |
CN112794910B (zh) | 一种抗pd-1的纳米抗体及其应用 | |
CN111925425B (zh) | 甲胎蛋白特异性结合多肽及应用 | |
CN110981959B (zh) | Cd47单域抗体、核苷酸序列、表达载体及试剂盒 | |
CN112250765A (zh) | 一种针对her2的纳米抗体及其应用 | |
CN107857816B (zh) | 一种抗干扰素α-2b纳米抗体及其应用 | |
CN106928359B (zh) | 一种CD105纳米抗体Nb59 | |
CN106928360B (zh) | 一种CD105纳米抗体Nb68 | |
CN108508216B (zh) | 抗人bFGF纳米抗体检测bFGF的方法及试剂盒 | |
US10995153B2 (en) | Polypeptide selectively binding to immunoglobulin G of mouse or rabbit and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190809 Address after: 361100 No. 201 Shuangfu South Road, Tong'an District, Xiamen City, Fujian Province Applicant after: XIAMEN TOBEFAR TECHNOLOGY Co.,Ltd. Address before: 100094 No. 1 Building, No. 13 Chuihunan Ring Road, Sujiatuo Town, Haidian District, Beijing Applicant before: BEIJING INSTITUTE OF COLLABORATIVE INNOVATION |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 361199 No. 201 Shuangfu South Road, Tong'an District, Xiamen City, Fujian Province Applicant after: Xiamen Baiyi Taipu Technology Co.,Ltd. Address before: 361100 No. 201, Shuangfu South Road, Tong'an District, Xiamen City, Fujian Province Applicant before: XIAMEN TOBEFAR TECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220419 Address after: 100094 Building 1, yard 13, cuihunan Ring Road, Haidian District, Beijing Applicant after: BEIJING INSTITUTE OF COLLABORATIVE INNOVATION Address before: 361199 No. 201 Shuangfu South Road, Tong'an District, Xiamen City, Fujian Province Applicant before: Xiamen Baiyi Taipu Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |